Chemistry

Photo
12.12.2023 • TopicsChemistry

The Green Power of Catalysis

With more than 80% of all chemical products manufactured using catalytic processes, catalysts are the number one value generator in the chemical industry.

Photo
17.05.2023 • NewsChemistry

Johnson Matthey Set to Catalyze the Net Zero Transition

Johnson Matthey (JM) looks back at a legacy of 200+ years. Established in 1817, the London, England-based chemical company reported annual revenues of about €18 billion in 2022. JM has built a global presence with operations in more than 30 countries. The company’s strategy is based on the vision for a cleaner, healthier world and mirrors society’s need to create a more sustainable future. JM has set out to catalyze the net zero transition by delivering sustainable solutions to customers enabled by innovative technology and leading positions in JM’s key markets automotive, chemicals, and energy. To get a better understanding of the role JM’s technological developments play for a sustainable future, Michael Reubold spoke with Maurits van Tol, the company’s Chief Technology Officer.

Photo
01.05.2023 • NewsChemistry

Small Particles with a Big Impact

In 2022, the European Commission revised the definition of nanomaterials in a new recommendation, which supports a uniform EU regulatory framework and aims at aligning the legislation across various sectors. Therefore, particle product design is an enabling technology relevant for many sectors, such as chemicals, consumer products, foods and beverages, health, energy, and the environment.

Photo
24.10.2022 • NewsChemistry

Rewriting the Rules for Chemical Distribution

Having survived the pandemic so far in good condition, chemical distributors are well positioned to grow, provided they understand how the rules for winning have changed. Distributors that keep their customers’ needs front and center will be best positioned to succeed, regardless of what the future brings.

Photo
03.06.2022 • TopicsChemistry

Proactive Supplier Risk Mitigation for Manufacturing and Testing Organizations

There is a new urgency in the market for manufacturers and testing organizations to be prepared for rapid, unexpected changes in material resource access, exacerbated by turbulent regional and global events. This focus is in addition to reinforcing routine risk mitigation activities around the raw material supply chain, adding to the relevance and impact of the topic.

Photo
18.05.2022 • NewsChemistry

Planning for the Unexpected

Dorothee Arns, Director General of FECC, discusses current challenges, market trends and her vision for the chemical distribution industry in Europe. The interview was conducted by Michael Reubold and Ralf Kempf.

Photo
02.05.2022 • NewsChemistry

Shaping the Future of the Pharma Industry

The International Society for Pharmaceutical Engineering (ISPE) announced the 2022 Facility of the Year Awards (FOYA) Category Winners – including an Honorable Mention for Iovance Biotherapeutics, to be the first company in the world to commercially produce a personalized therapy for solid tumors.

Photo
19.04.2022 • NewsChemistry

Dealing with Price Volatility

It sometimes seems that everyone running a business always thinks that times are tougher now than they used to be. For producers — and buyers — of commodity chemicals, this thinking will take the more specific form of concerns about increased price volatility.

Photo
19.04.2022 • NewsChemistry

The Supply Chain Dilemma

Since the middle of the 1980s, the supply chain of many chemicals has moved east. This was primarily driven by cheaper production costs in China or India, due to lower raw material prices, a cheaper asset base compared to plants in the West, and lower environmental and regulatory standards.

Photo
19.04.2022 • NewsChemistry

Where Science Meets Business

From its inception in 1881, SCI's principal objective has been to further the application of chemistry and related sciences into industry for the public benefit.

Photo
15.04.2022 • TopicsChemistry

Expanding Into Oligonucleotides

The global market for oligonucleotide therapeutics is expanding rapidly. Bachem, an innovation-driven company based in Bubendorf, Switzerland, has entered this competitive environment a few years ago and meanwhile has passed certain milestones on its way to become a preferred oligonucleotide manufacturing partner for pharmaceutical companies.

Photo
26.11.2021 • NewsChemistry

Bioscience Trends in China’s New Five-Year Plan

China’s 14th Five-Year Plan “145” suggests that the dynamics initiated by the previous Five-Year Plan are to be maintained and even surpassed. As in the previous planning period, high priority is given to modernizing the country and the economy through R&D.

528 more articles

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.